Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG-4592 (Roxadustat) vs Epoetin Alfa in ESRD Anemia
NCT01596855Phase 2Completed
- Sponsor
- FibroGen
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roxadustat in anemia of chronic kidney disease (CKD-A), sponsored by FibroGen. Started Sep 2011; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01596855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01596855.